Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Temozolomide (20mg) Capsule
Therapeutic Category
Neurology, Oncology, Anticancer
Dosage Form
Capsule
Packaging Type
in a Bottle
Packaging
30 Capsules
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Temofan 20 Capsule contains Temozolomide 20mg, an oral alkylating agent widely used in the treatment of primary brain tumors such as glioblastoma multiforme and astrocytoma. It helps in slowing tumor growth and improving survival outcomes in patients with aggressive brain cancers.
Temozolomide works by alkylating/methylating DNA in cancer cells, which disrupts DNA replication and triggers cancer cell death. This mechanism allows it to target rapidly dividing tumor cells selectively while sparing most normal cells.
This capsule is commonly prescribed as part of adjuvant therapy or combination therapy with radiotherapy for brain tumors. Its oral formulation provides convenience for patients requiring long-term cancer management, enhancing adherence to treatment protocols.
For PCD pharma franchise partners, Temofan 20 Capsule is a high-demand oncology product, available at the best price for PCD pharma franchise. Its strong clinical demand, prescriber trust, and essential role in brain tumor management make it a valuable addition to any cancer care or oncology product portfolio.
Common side effects may include nausea, vomiting, fatigue, loss of appetite, and mild headache. Rare but serious side effects include bone marrow suppression, infections due to low blood counts, liver toxicity, or severe allergic reactions. Patients should seek immediate medical attention if severe symptoms occur.
Temofan 20 Capsule is indicated for the treatment of adult patients with newly diagnosed glioblastoma in combination with radiotherapy, as well as for recurrent anaplastic astrocytoma, as prescribed by a healthcare professional.
Temofan 20 Capsule should be taken exactly as prescribed, typically on an empty stomach. Regular monitoring of blood counts, liver function, and overall health is essential during therapy. Patients should inform their doctor of any history of infections, liver disease, or concurrent medications.
Store Temofan 20 Capsule in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiry date indicated on the packaging.
Composition : Paracetamol (250mg/5ml)
Composition : Ibuprofen (100mg) + Paracetamol (125mg)
Composition : Paracetamol (1000mg) Infusion
Composition : Ketorolac (30mg) Injection
Composition : Mefenamic Acid (100mg) + Paracetamol (250mg)
Composition : Mefenamic Acid (50mg) + Paracetamol (125mg)
Composition : Diclofenac diethylamine (1.16% w/v) + Linseed Oil (3% w/v) + Methyl Salicylate (10% w/v) + Menthol (5% w/v)
Composition : Diclofenac diethylamine (1.16% w/w) + Thiocolchicoside (0.125% w/w) + Linseed Oil (3.0% w/w) + Methyl Salicylate (10.0% w/w) + Menthol (5.0% w/w)
Composition : Choline Salicylate (8.7% w/w) + Lidocaine (2.0% w/w) + Benzalkonium Chloride (0.01% w/w) Gel
Composition : Flupirtine (100mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Temozolomide 20mg Capsule has demand in the oncology, hospital care, and specialty healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cancer care and specialty pharmaceutical portfolios.
Medical distributors and agencies can benefit from demand for oncology treatment support under specialist medical supervision. Temozolomide 20mg is an antineoplastic (anticancer) medication used in specific cancer treatment protocols Commonly prescribed for the management of certain brain tumors, including glioblastoma multiforme and anaplastic astrocytoma, as advised by oncologists Helps inhibit the growth and multiplication of cancer cells as part of a comprehensive treatment regimen Frequently used in combination with radiotherapy or other oncology treatment approaches depending on the patient's condition Oral capsule formulation offers convenience in administration as directed by healthcare professionals Widely prescribed by oncologists, neuro-oncologists, and cancer care specialists This strengthens a comprehensive oncology and specialty care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Temozolomide 20mg Capsule with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from specialty healthcare demand, hospital procurement opportunities, reliable supply chain support, repeat orders from oncology centers, and attractive margins in the oncology segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.